EMC
60
2
MMC
55
-2
EMR
70
2
SEE
55
5
AA
72
2
CPB
39
2
KSS
62
2
VZ
44
-11
ACN
50
-6
MLM
66
3
CL
58
2
DE
45
-3
KMB
42
-3
LEG
61
-3
ED
36
2
ORCL
37
3
VNO
49
8
PSX
42
3
ETN
65
-2
DIS
70
10
EMC
60
2
MMC
55
-2
EMR
70
2
SEE
55
5
AA
72
2
CPB
39
2
KSS
62
2
VZ
44
-11
ACN
50
-6
MLM
66
3
CL
58
2
DE
45
-3
KMB
42
-3
LEG
61
-3
ED
36
2
ORCL
37
3
VNO
49
8
PSX
42
3
ETN
65
-2
DIS
70
10
Financhill
Back

Pliant Therapeutics, Inc. 10K Form

Sell
17

PLRX
Pliant Therapeutics, Inc.

Last Price:
$1.19
Seasonality Move:
-3.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PLRX News And Ratings

See the #1 stock for the next 7 days that we like better than PLRX

PLRX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-21.1M
Price / Cash Flow: 0
Annual Sales: $3.26
Price / Book: 0.37

Profitability

EPS (TTM): -2.86830
Net Income (TTM): $-175.5M
Gross Margin: $-2.1M
Return on Equity: -66.1%
Return on Assets: -49.75%

Pliant Therapeutics, Inc. Earnings Forecast

Key Pliant Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 2 years.

Pliant Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PLRX
CUSIP: 729139
Website: pliantrx.com

Debt

Debt-to-Equity Ratio: 0.3
Current Ratio: 13.93
Quick Ratio: 13.72

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PLRX Technical Analysis vs Fundamental Analysis

Sell
17
Pliant Therapeutics, Inc. (PLRX) is a Sell

Is Pliant Therapeutics, Inc. a Buy or a Sell?